Philadelphia, PA- (Accesswire) - Olfactory Biosciences Corp. (OLFC) the makers of NOXO Autism Balm(TM) are pleased to announce today that we are listening to customers and that many have mentioned the difficult economy and how it is making it a hardship for them to afford NOXO Autism Balm(TM). In response OLFC we would like to show our dedication to our new friends in the Autism community by lowering the price to $29.95 on a trial basis. If purchase volumes continue to dramatically increase and help us justify this price drop it will remain permanent in order to remain affordable for those who need it.
We are excited to share in improving the lives of these great families affected by Autism. We are also pleased that the feedback continues to support that we are helping individuals, families and care facilities to provide a more peaceful and calming experience for people with sensitivities. NOXO Autism Balm(TM) is ending the isolation experienced by individuals and families affected by Autism Spectrum Disorders (ASD).
NOXO Autism Aid(TM) is similar to a lip balm but is applied just below the nostrils on the upper lip. Allowing the natural formula to be inhaled and take effect. NOXO’s solution is safe, easy to apply and non-invasive. It works on your body’s natural processes and responses. It is the first product to address behavioral issues triggered by sensitivities.
You can get more information on NOXO Autism Aid(TM) at www.noxoinfo.com/autism.html
About Olfactory Biosciences Corp
Olfactory Biosciences Corp.’s NOXO division is focused to develop a variety of products targeting Olfactory Receptors for the desired effect. These alternative medicine wellness products may modify behavior or provide relief to common behavior challenges such as anxiety, smoking or weight control, as examples. www.noxoinfo.com/investor
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding ales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company's products or the need to raise additional capital. In addition, actual results could vary materially based on changes or slower growth in the indoor garden market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
Richard Stevenson, President
Olfactory Biosciences Corp.
333 E. Lancaster Ave. Suite 317
Wynnewood, PA 19096, USA
Source: Olfactory Biosciences Corp.
Leave a comment...